# Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-biomarker-results-from-phase-i-ii-study-of-pi3k-inhibitor-alpelisib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Priyanka Sharma,Vandana G. Abramson,Anne O’Dea,Lauren Nye,Ingrid A. Mayer,Harsh B. Pathak,Marc Hoffmann,Shane R. Stecklein,Manana Elia,Sharon L. Lewis,Jecinta Scott,Jilliann A. De Jong,Yen Y. Wang,Rachel Yoder,Kelsey Schwensen,Karissa Finke,Jaimie Heldstab,Stephanie LaFaver,Stephen K. Williamson,Milind A. Phadnis,Gregory A. Reed,Bruce F. Kimler,Qamar J. Khan,Andrew K. Godwin |
| Citations | 85 |
| DOI | 10.1158/1078-0432.ccr-20-4879 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/27/14/3896/3087442/3896.pdf |
| OpenAlex ID | https://openalex.org/W3131053290 |
| PMID | 33602685 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Milind A. Phadnis](https://scholariq.org/researchers/milind-a-phadnis/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.